Allurion Technologies, Inc. (ALUR): Gross Profit
$9.57M
Year ended 2025-12-31
$6.64M
Trailing 12 months to 2026-03-31
-42.6%
3-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $9.57M | -55.5% | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | $21.50M | -48.2% | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | $41.50M | -18.2% | 2025-08-28, From 2023-01-01 |
| 2022-12-31 | $50.73M | n/a | 2025-08-28, From 2022-01-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| Allurion Technologies, Inc. (ALUR) | 2025-12-31 | $9.57M | -55.5% |
| Biotricity Inc. (BTCY) | 2026-03-31 | $12.95M | +22.6% |
| Profound Medical Corp. (PROF) | 2025-12-31 | $11.39M | +61.9% |
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | $10.54M | +16.9% |
| Nephros Inc (NEPH) | 2025-12-31 | $11.62M | +33.3% |
| Sonoma Pharmaceuticals, Inc. (SNOA) | 2026-03-31 | $7.42M | +35.7% |
| Spectral AI, Inc. (MDAI) | 2025-12-31 | $8.93M | -32.8% |
| Nexgel, Inc. (NXGL) | 2025-12-31 | $4.51M | +64.1% |
| DarioHealth Corp. (DRIO) | 2025-12-31 | $12.66M | -4.5% |
Compare ALUR, BTCY, PROF, VVOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗